OR WAIT 15 SECS
March 01, 2021
Joins network of manufacturers contributing efforts to increase supply
February 25, 2021
Joins UK consortium to help efficiently manufacture oral solid dosage medication
February 23, 2021
Company says it will be able to produce an estimated 12 million doses per month
February 19, 2021
The importance of thinking strategically about the infrastructure and foresight needed to scale up CGTs—not as treatments of last resort, but first choice
February 18, 2021
Lab development project features 9,000-square-foot expansion
February 10, 2021
Results address concerns surrounding bulk passive pharma packaging
February 06, 2021
$180M collaboration aims to introduce multiple vaccine candidates in 2022
February 05, 2021
Two-dose COVAXIN currently under EUA in India
Rating for packaging supplier highlights its commitment to sustainable practices and corporate social responsibility
February 02, 2021
In Phase III at the moment, mRNA dose will be produced at Bayer's Wuppertal, Germany facility
January 30, 2021
Production expected to begin in the second quarter
January 23, 2021
Boston-area location will be fully operational in Q4
January 22, 2021
Latest air cargo collaboration provides pandemic response support
January 12, 2021
Unnamed US facility will increase company's manufacturing capacity
January 11, 2021
These organizations are encouraged to consider all alternatives when planning their packaging, serialization and validation strategies
January 04, 2021
Liquid pharmaceuticals can serve as needed alternatives in hospitals and other care settings
December 22, 2020
Acquisition grows company's chemical manufacturing and R&D network
December 19, 2020
Strike partnership deal focused on manufacturing and commercialization services
December 17, 2020
Carlsbad structure will house material for cell and gene-based therapies
Resource aims to boost tech aptitude in temperature-controlled packaging field
